Last update:
Medications news
Medications
Sedative choice could improve outcomes for breathing tube patients
Doctors treating seriously ill patients in an emergency setting may want to give the sedative etomidate, rather than ketamine, while placing a breathing tube, according to a randomized trial published in the New England Journal ...
14 hours ago
0
6
Medications
How a rare drug made from scientists' blood saves babies from botulism
When Alessandro Barbera was rushed to a California hospital with infant botulism in October, his father had barely heard of the disease, never mind the rare and costly treatment that likely saved the newborn's life.
19 hours ago
0
0
Some blood pressure pills recalled for possible contamination
A widely used blood pressure medication is being pulled from shelves after testing suggested some batches may contain traces of other drugs.
20 hours ago
0
0
Online tool detects drug exposure directly from patient samples
Doctors and researchers try to understand what medications a person has taken by asking patients directly or by looking at medical records. But this information is often incomplete. People may forget what they took, use over‑the‑counter ...
Dec 9, 2025
0
9
Fish oil supplement halves serious cardiovascular events in patients on dialysis, clinical trial finds
A daily fish oil supplement has been shown to significantly reduce serious cardiovascular events in people receiving dialysis for kidney failure. The findings come from a major international clinical trial co-led in Australia ...
Dec 8, 2025
0
88
Anti-platelet drug can slow metastasis in aggressive cancers, research shows
Aggressive cancers can use blood vessels like roadways, speeding through the body and finding new places to grow. But new research shows that a drug in clinical trials may help stop the spread of cancer before it reaches ...
Dec 8, 2025
0
0
An existing drug may improve ovarian cancer treatment
Hua-Ying Fan, PhD, hopes that her team's latest discovery could help the almost 21,000 people who are expected to receive an ovarian cancer diagnosis this year.
Dec 8, 2025
0
0
Opioid use linked to higher risk of C. difficile infection
New research from the University of Georgia suggests that opioid use could make patients more vulnerable to infections.
Dec 8, 2025
0
0
Telling people to use antibiotics responsibly isn't enough. What will work instead?
Antimicrobial resistance is projected to cause up to 10 million deaths each year by 2050, making it one of the most pressing global health challenges of this century. In 2021, an estimated 4.71 million deaths were associated ...
Dec 8, 2025
0
0
Men and women may need different medications to avoid broken bones
A new international study published in Osteoporosis International and led by Monash's Center for Medicine Use and Safety (CMUS) has investigated the risks of a second hip fracture, subsequent fractures, and death in people ...
Dec 8, 2025
0
0
Medical cannabis linked to reduced opioid use in adults with chronic pain
Adults with chronic pain who participated in New York State's (NYS) Medical Cannabis Program were significantly less likely to require prescription opioids, according to a new study published in JAMA Internal Medicine and ...
Dec 8, 2025
0
0
Potentially life-threatening medicine interactions combated with new database
A comprehensive webpage-based database, named as IMgateway, currently offers rigorous, evidence-based information on the integration of complementary and conventional medicine but has lacked data on Chinese herbal medicines—until ...
Dec 8, 2025
0
0
Time to legalize psychedelics? Campus debate weighs therapeutic need vs. safety questions
Debate over psychedelic legalization tends to focus on two extreme views: the need to speed therapeutic access to meet urgent problems such as veteran suicide, and calls to thoroughly research substances first to ensure they ...
Dec 8, 2025
0
0
FDA approves Itvisma for spinal muscular atrophy
The U.S. Food and Drug Administration has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in patients 2 years and older with confirmed mutation in the survival motor neuron ...
Dec 8, 2025
0
0
Emergency departments fall short on delivering timely treatment for sickle cell pain, study finds
A new study finds that only one in three patients visiting emergency departments (EDs) for severe pain associated with sickle cell disease received appropriate opioid-based pain-relieving medications within the first hour ...
Dec 6, 2025
0
0
Study shows no clear evidence of harm from hydroxyurea use during pregnancy
Taking the sickle cell drug hydroxyurea during or shortly before pregnancy does not appear to cause specific issues in newborns, according to the first prospective study of pregnancies involving hydroxyurea exposure. The ...
Dec 6, 2025
0
0
Study finds cystic fibrosis drug allows patients to safely scale back lung therapies
A new multi-site study led by researchers at CU Anschutz shows that people with cystic fibrosis (CF) who start the triple-drug therapy elexacaftor/tezacaftor/ivacaftor (ETI) can safely reduce many of their daily lung treatments ...
Dec 5, 2025
0
68
Innovative drug delivery mechanism triggered by cooling could provide targeted pain relief
Leon Bellan, associate professor of mechanical and biomedical engineering at Vanderbilt, and his team have developed a novel cooling-triggered device that could allow patients to safely and conveniently receive drugs for ...
Dec 5, 2025
0
0
GLP-1RAs shown to reduce risk of cardiovascular death
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide, liraglutide, and tirzepatide are widely prescribed both for Type 2 diabetes and weight loss. These drugs also have shown promise in clinical trials ...
Dec 5, 2025
0
0
New UK guideline for clopidogrel recommends pharmacogenetic testing for all patients before prescription
The UK Center of Excellence in Regulatory Science and Innovation in Pharmacogenomics (UK CERSI-PGx), led by the University of Liverpool, has published its first clinical guideline focused on the use of the antiplatelet medication ...
Dec 4, 2025
0
1
Experimental drug repairs DNA damage caused by common diseases
Cedars-Sinai scientists have developed an experimental drug that repairs DNA and serves as a prototype for a new class of medications that fix tissue damage caused by heart attack, inflammatory disease or other conditions.
Dec 3, 2025
0
51
Pegcetacoplan—the 'closest thing to a cure' for rare, severe kidney disease
A rare and life-threatening kidney disease in children finally has an effective therapy, thanks in large part to pioneering research and clinical leadership from University of Iowa Health Care Stead Family Children's Hospital.
Dec 3, 2025
0
41
Consumers pay when drugmakers delay, finds study of over-the-counter drug exclusivity rules
Policies designed to encourage drugmakers to introduce over-the-counter (OTC) versions of previously prescription-only medications may in fact harm consumers, shows a new study co-authored by a University of Massachusetts ...
Dec 3, 2025
0
0
Long-term antidepressant use surges in Australia, sparking warnings of overprescribing
Long-term antidepressant use in Australia has risen steadily over the past decade, with the largest increase seen in young people aged 10–24, where rates have more than doubled.
Dec 3, 2025
0
0
Recent changes to EU chemicals legislation are rarely reflected in the EU pharmaceutical sector
Several changes have been made to EU chemicals policy and legislation with the aim of making society greener. These changes may affect the pharmaceutical sector in many ways, but they are rarely reflected in pharmaceutical ...
Dec 3, 2025
0
0
